Algo could potentially start to rebound in the coming quarters '23e-'25e sales down 9-15% '24e EV/EB...
Medicinteknikbolaget Tendo redovisade ingen nettoomsättning och ökad rörelseförlust i det tredje kva...
Equity analyst Markus Almerud discusses Zwipe after the announcement of the rights issue.
ChargePanel publicerade den 14 november år 2023 bolagets delårsrapport för det tredje kvartal 2023.
Rapportkommentar Q3 Corlines Q3-rapport levde inte upp till marknadens förväntningar.
Låg sportboksmarginal pressar tillväxt och lönsamhet Omsättningen i kvartalet uppgick till EUR 9,9m,...
Q3 EBITDA of -0.3m vs ABGSCe 0.9m Strong financial position - Holds SEK 6.
Back into black numbers, adj. EBITA SEK 10.8m (21.6m) Lower sales but higher EBIT for '24e Stable de...
Exel’s CMD added details to its new strategy. Many important decisions are still to be worked out, b...
Redeye judges Fluoguide’s phase IIb trial with FG001 in high-grade glioma meeting its primary endpoi...
Redeye comments on EG7’s Q3-results where topline came in below expectations while EBITDA was better...
Redeye makes positive estimate revisions on the back of Bredband2’s strong Q3 2023 report that beat ...
Ferronordic has entered into an agreement to purchase Rudd Equipment Company, Inc.
Q3: EBITDA NOK 4m – soft but broadly in line with our NOK 5m 2025 ambitions kept, company needs larg...
Biovica has established a partnership agreement with Axlab (A/S) to commercialize the DiviTum in the...
Bolaget har tecknat en ny stororder inom AI-infrastruktur med en framstående kund inom fordonsindust...
Redeye endorses Inhalation Sciences’ order worth approximately SEK3.
Lönsamheten viker i kvartalet Omsättningen i kvartalet uppgick till 633 mkr vilket rensat för valuta...
Q3-resultatet indikerar stabilitet i verksamheten Nettoomsättningen sjönk med 4,1% till 173,3 mkr (1...
Mendus’s Q323 update was primarily focused on the clinical progression of its lead cancer vaccine, v...
